BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3402040)

  • 1. Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.
    DiGiovanni J; Kruszewski FH; Coombs MM; Bhatt TS; Pezeshk A
    Carcinogenesis; 1988 Aug; 9(8):1437-43. PubMed ID: 3402040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants.
    Battalora MS; Kruszewski FH; DiGiovanni J
    Carcinogenesis; 1993 Dec; 14(12):2507-12. PubMed ID: 8269619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal ornithine decarboxylase induction and mouse skin tumor promotion by quinones.
    Monks TJ; Walker SE; Flynn LM; Conti CJ; DiGiovanni J
    Carcinogenesis; 1990 Oct; 11(10):1795-801. PubMed ID: 2119908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of mouse skin tumor promotion by chrysarobin.
    DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
    Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of chrysarobin skin tumor promotion.
    DiGiovanni J; Kruszewski FH; Chenicek KJ
    Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of application frequency on epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice.
    Kruszewski FH; Chenicek KJ; Digiovanni J
    Cancer Lett; 1986 Sep; 32(3):263-9. PubMed ID: 3768852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic alterations produced by chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: relationship to skin tumor promoting activity.
    Kruszewski FH; Naito M; Naito Y; DiGiovanni J
    J Invest Dermatol; 1989 Jan; 92(1):64-71. PubMed ID: 2462598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
    Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
    Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
    Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
    Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice.
    Battalora MS; Johnston DA; DiGiovanni J
    Cancer Lett; 1995 Nov; 98(1):19-25. PubMed ID: 8529201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
    Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
    J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by retinoids of anthralin-induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation.
    Dawson MI; Chao WR; Helmes CT
    Cancer Res; 1987 Dec; 47(23):6210-5. PubMed ID: 3677072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice.
    DiGiovanni J; Boutwell RK
    Carcinogenesis; 1983; 4(3):281-4. PubMed ID: 6831635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
    Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
    Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in epidermal polyamine levels and DNA synthesis following topical treatment with chrysarobin in SENCAR mice.
    Kruszewski FH; DiGiovanni J
    Cancer Res; 1988 Nov; 48(22):6390-5. PubMed ID: 3180057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 1,8-dihydroxy-9-anthrone (anthralin) on rat hepatic ornithine decarboxylase activity in vivo.
    Bisschop A; Vankan PM; Uijtewaal B; van Wijk R
    Cancer Lett; 1984 Jun; 23(2):151-7. PubMed ID: 6744241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
    De Young LM; Helmes CT; Chao WR; Young JM; Miller V
    Cancer Res; 1981 Jan; 41(1):204-8. PubMed ID: 7448761
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of a functionally altered ornithine decarboxylase activity in chrysarobin-promoted mouse epidermal papillomas.
    O'Brien TG; O'Donnell K; Kruszewski FH; DiGiovanni J
    Carcinogenesis; 1988 Nov; 9(11):2081-5. PubMed ID: 3141077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.